{
  "issued_date": "2010-06-15", 
  "original_url": "http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON084844", 
  "doc_details": {
    "Type": "Medical Device Alert", 
    "Series No": "MDA/2010/050", 
    "Audience": "Healthcare professionals", 
    "Published": "15 June 2010 at 15:00", 
    "Format": "Electronic only", 
    "Size": "A4", 
    "Pages": "4", 
    "Price": "Free", 
    "ISBN/ISSN": "", 
    "Author": "", 
    "Copyright": "Crown"
  }, 
  "_assets": [
    {
      "content_type": "image/jpeg", 
      "title": "Medical Device Alert: Implantable vagus nerve stimulators (VNS) manufactured by Cyberonics VNS Therapy (MDA/2010/050)", 
      "assetid": 0, 
      "original_url": "http://www.mhra.gov.uk/idcm2/groups/dts-bs/documents/medicaldevicealert/con084869.jpg", 
      "filename": "downloads/fdea263e2a7bc2c0e08ae147a58819a163f4d532/con084869.jpg", 
      "original_filename": "con084869.jpg"
    }
  ], 
  "body": "## Device\n\n![ASSET_TAG](#ASSET0)Implantable vagus nerve stimulators (VNS):  \n  \n  * Pulse and Pulse Duo Generators (Models 100, 101, 102 and 102R)  \n  * Demipulse and Demipulse Duo Generators (Models 103 and 104)  \n  * Model 250 programming software.  \n  \nManufactured by Cyberonics VNS Therapy.\n\n## Problem  \n  \n  * Premature battery depletion (models 103 and 104).  \n  * Inaccurate battery life projection (models 103, 104 and 250).  \n  * Loss of therapy (all models).  \n  * Painful, erratic or atypical stimulation (all models).  \n  \nThe MHRA has issued this Medical Device Alert (MDA) to support Cyberonics\u2019 corrective actions, as\u00a0it has informed us that to date there has been a low level of response to\u00a0its Field Safety Notices (FSNs) listed below.\n\nIn July 2009 Cyberonics issued a [FSN](http://www.mhra.gov.uk/home/ssLINK/CON052005) concerning Model 250 Programming software when used with Pulse and Pulse Duo Generators (Models 100, 101, 102 & 102R) and Demipulse and Demipulse Duo Generators (Models 103 and 104).\n\nIn November 2009 Cyberonics issued a [FSN](http://www.mhra.gov.uk/home/ssLINK/CON065475) concerning the Demipulse and Demipulse Duo Generators (Models 103 and 104).\n\nIn April 2010 Cyberonics issued a [FSN](http://www.mhra.gov.uk/home/ssLINK/CON079088) concerning Model 250 Programming software when used with Demipulse and Demipulse Duo Generators (Models 103 and 104).\n\nCyberonics has requested that clinicians contact\u00a0its team\u00a0as soon as possible if they should have received any of the above FSNs but did not. It is important to follow the actions advised in FSNs, and for your organisation to acknowledge receipt of FSNs. The receipt provides the manufacturer, and subsequently the MHRA, with the means to monitor the progress of Field Safety Corrective Actions. It also minimises the need for the MHRA to issue MDAs, which otherwise place an additional burden on the health service because of the broadcast nature of the MDA and the extra administrative work required.1\n\n1 [Reporting Adverse Incidents and Disseminating Medical Device Alerts - DB 2010(01)](http://www.mhra.gov.uk/home/ssLINK/CON111565)\n\n## Action  \n  \n  * Follow the advice in the manufacturer\u2019s Field Safety Notices (FSNs) issued in:  \n  *     * [July 2009](http://www.mhra.gov.uk/home/ssLINK/CON052005)  \n    * [November 2009](http://www.mhra.gov.uk/home/ssLINK/CON065475)  \n    * [April 2010](http://www.mhra.gov.uk/home/ssLINK/CON079088)  \n  * Ensure that you acknowledge each FSN that applies to your organisation by returning the receipt to the manufacturer.  \n  \n## Distribution\n\nThis MDA has been distributed to:  \n  \n  * NHS trusts in England (Chief Executives)  \n  * HSC trusts in Northern Ireland (Chief Executives)  \n  * NHS boards in Scotland (Chief Executives)  \n  * NHS boards and trusts in Wales (Chief Executives)  \n  * Primary care trusts in England (Chief Executives)  \n  \nOnward distribution\n\nPlease bring this notice to the attention of all who need to know or be aware of it. This may include distribution by:\n\nTrusts to:  \nCAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:  \n  \n  * A&E consultants  \n  * A&E departments  \n  * A&E directors  \n  * A&E nurses  \n  * Adult intensive care units  \n  * All departments  \n  * All staff  \n  * All wards  \n  * Anaesthetists  \n  * Clinical governance leads  \n  * Day surgery units  \n  * Equipment stores  \n  * General surgeons  \n  * General surgery  \n  * General surgical units, directors of  \n  * Health and safety managers  \n  * In-house maintenance staff  \n  * Medical directors  \n  * Medical oncologists  \n  * MRI units, directors of  \n  * Nursing executive directors  \n  * Neurological surgeons  \n  * Neurology and neurosurgery departments  \n  * Occupational therapists  \n  * Oncology nurse specialists  \n  * Outpatient clinics  \n  * Outpatient theatre managers  \n  * Outpatient theatre nurses  \n  * Palliative care teams  \n  * Purchasing managers  \n  * Radiation and medical oncology departments  \n  * Radiation oncology, directors of  \n  * Radiographers  \n  * Radiologists  \n  * Radiology departments  \n  * Radiology directors  \n  * Risk managers  \n  * Supplies managers  \n  * Theatre managers  \n  * Theatre nurses  \n  * Theatres  \n  \nCare Quality Commission (CQC) (England only) to:  \nThe MHRA considers this information to be important to:  \n  \n  * Hospices  \n  * Hospitals in the independent sector  \n  * Independent treatment centres  \n  * Private medical practitioners  \n  \nPrimary care trusts to:  \nCAS liaison officers for onward distribution to all relevant staff including:  \n  \n  * Directors of public health  \n  * Palliative care team  \n  * Practice managers  \n  * Practice nurses  \n  \n## Manufacturer Contact\n\nJohn Forsey  \nCyberonics Europe  \nUnit 4 Dunston Innovation Centre  \nDunston Road  \nChesterfield\u00a0  \nS41 8NG\n\nTel: 01246 261 397  \nFax: 0870 166 0501\u00a0\n\nEmail: [europeclintechservices@cyberonics.com](mailto:europeclintechservices@cyberonics.com)\u00a0\n\n## Feedback\n\nIf you have any comments or feedback on this Medical Device Alert, please email us at: [dts@mhra.gsi.gov.uk](mailto:dts@mhra.gsi.gov.uk)\u00a0\n\n## England\n\nIf you are in England, please send enquiries about this notice to the MHRA, quoting reference number MDA/2010/050.\n\nTechnical aspects  \nSimon Holmes or Feza Haque  \nMedicines & Healthcare products Regulatory Agency\u00a0  \nMarket Towers\u00a0  \n1 Nine Elms Lane  \nLondon  \nSW8 5NQ\n\nTel: 020 7084 3240 / 3066  \nFax: 020 7084 3106\n\nEmail: [simon.holmes@mhra.gsi.gov](mailto:simon.holmes@mhra.gsi.gov)\u00a0or [feza.haque@mhra.gsi.gov.uk](mailto:feza.haque@mhra.gsi.gov.uk)\u00a0\n\nClinical aspects  \nDr Susanne Ludgate  \nMedicines & Healthcare products Regulatory Agency  \nMarket Towers  \n1 Nine Elms Lane  \nLondon SW8 5NQ  \n  \nTel: 020 7084 3123  \nFax: 020 7084 3111\u00a0\n\nEmail: [susanne.ludgate@mhra.gsi.gov.uk](mailto:susanne.ludgate@mhra.gsi.gov.uk)\n\nHow to report adverse incidents  \nPlease report via our website: [Reporting adverse incidents involving medical devices](http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Devices/index.htm).  \n  \nFurther information about CAS can be found on the [Central Alerting System website](https://www.cas.dh.gov.uk/Home.aspx) (external link).\n\n## Northern Ireland\n\nAlerts in Northern Ireland will continue to be distributed via the NI SABS system.\n\nEnquiries and adverse incident reports in Northern Ireland should be addressed to:\n\nNorthern Ireland Adverse Incident Centre  \nHealth Estates Investment Group  \nRoom 17  \nAnnex 6  \nCastle Buildings  \nStormont Estate  \nDundonald  \nBT4 3SQ\n\nTel: 02890 523 704  \nFax: 02890 523 900\n\nEmail: [NIAIC@dhsspsni.gov.uk](mailto:NIAIC@dhsspsni.gov.uk)\n\n[Northern Ireland Adverse Incident Centre (NIAIC)](http://www.dhsspsni.gov.uk/index/hea/niaic.htm) (external link)\n\nHow to report adverse incidents in Northern Ireland  \nPlease report directly to NIAIC, further information can be found on the [NIAIC website](http://www.dhsspsni.gov.uk/niaic) (external link).  \nFurther information about SABS can be found on the [SABS website](http://sabs.dhsspsni.gov.uk/) (external link).\n\n## Scotland\n\nEnquiries and adverse incident reports in Scotland should be addressed to:\n\nIncident Reporting and Investigation Centre  \nHealth Facilities Scotland  \nNHS National Services Scotland  \nGyle Square  \n1 South Gyle Crescent  \nEdinburgh  \nEH12 9EB\n\nTel: 0131 275 7575  \nFax: 0131 314 0722\n\nEmail: [nss.iric@nhs.net](mailto:nss.iric@nhs.net)\n\n[Health Facilities Scotland - Incident Reporting and Investigation Centre](http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/) (external link).\n\n## Wales\n\nEnquiries in Wales should be addressed to: \n\nDr Sara Hayes  \nSenior Medical Officer  \nMedical Device Alerts  \nWelsh Assembly Government  \nCathays Park  \nCardiff  \nCF10 3NQ\n\nTel: 029 2082 3922\n\nEmail: [Haz-Aic@wales.gsi.gov.uk](mailto:Haz-Aic@wales.gsi.gov.uk)\n", 
  "raw_html": "<div id=\"inner_tab_content\">\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n\t\t\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t<h2 class=\"sw\">Device</h2><div class=\"content_section active_content_section\" id=\"Device\">\r\n\t\t\t\t\t\t\t\t<p><span><font class=\"imageright\"><img src=\"#ASSET0\" alt=\"ASSET_TAG\"></font></span><span>Implantable vagus nerve stimulators (VNS):</span></p><ul>\r\n\t\t\t\t<li><span>Pulse and Pulse Duo Generators (Models 100, 101, 102 and 102R)</span></li>\r\n\t\t\t\t<li><span>Demipulse and Demipulse Duo Generators (Models 103 and 104)</span></li>\r\n\t\t\t\t<li><span>Model 250 programming software.</span></li></ul><p><span>Manufactured by Cyberonics VNS Therapy.</span></p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Problem</h2><div class=\"content_section\" id=\"Problem\">\r\n\t\t\t\t\t\t\t\t<ul>\r\n\t\t\t\t<li><span>Premature battery depletion (models 103 and 104).</span></li>\r\n\t\t\t\t<li><span>Inaccurate battery life projection (models 103, 104 and 250).</span></li>\r\n\t\t\t\t<li><span>Loss of therapy (all models).</span></li>\r\n\t\t\t\t<li><span>Painful, erratic or atypical stimulation (all models).</span></li></ul><p>The MHRA has issued this Medical Device Alert (MDA) to support Cyberonics&#8217; corrective actions, as&#160;it has informed us that to date there has been a low level of response to&#160;its Field Safety Notices (FSNs) listed below.</p><p>In July 2009 Cyberonics issued a <a href=\"http://www.mhra.gov.uk/home/ssLINK/CON052005\">FSN</a> concerning Model 250 Programming software when used with Pulse and Pulse Duo Generators (Models 100, 101, 102 &amp; 102R) and Demipulse and Demipulse Duo Generators (Models 103 and 104).</p><p>In November 2009 Cyberonics issued a <a href=\"http://www.mhra.gov.uk/home/ssLINK/CON065475\">FSN</a> concerning the Demipulse and Demipulse Duo Generators (Models 103 and 104).</p><p>In April 2010 Cyberonics issued a <a href=\"http://www.mhra.gov.uk/home/ssLINK/CON079088\">FSN</a> concerning Model 250 Programming software when used with Demipulse and Demipulse Duo Generators (Models 103 and 104).</p><p>Cyberonics has requested that clinicians contact&#160;its team&#160;as soon as possible if they should have received any of the above FSNs but did not. It is important to follow the actions advised in FSNs, and for your organisation to acknowledge receipt of FSNs. The receipt provides the manufacturer, and subsequently the MHRA, with the means to monitor the progress of Field Safety Corrective Actions. It also minimises the need for the MHRA to issue MDAs, which otherwise place an additional burden on the health service because of the broadcast nature of the MDA and the extra administrative work required.<font class=\"super\">1</font></p><p><font class=\"super\">1</font>\r\n\t\t\t\t<a href=\"http://www.mhra.gov.uk/home/ssLINK/CON111565\">Reporting Adverse Incidents and Disseminating Medical Device Alerts - DB 2010(01)</a></p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Action</h2><div class=\"content_section\" id=\"Action\">\r\n\t\t\t\t\t\t\t\t<ul>\r\n\t\t\t\t<li>Follow the advice in the manufacturer&#8217;s Field Safety Notices (FSNs) issued in:</li>\r\n\t\t\t\t<li style=\"list-style: none\">\r\n\t\t\t\t\t<ul>\r\n\t\t\t\t\t\t<li><a href=\"http://www.mhra.gov.uk/home/ssLINK/CON052005\">July 2009</a></li>\r\n\t\t\t\t\t\t<li><a href=\"http://www.mhra.gov.uk/home/ssLINK/CON065475\">November 2009</a></li>\r\n\t\t\t\t\t\t<li><a href=\"http://www.mhra.gov.uk/home/ssLINK/CON079088\">April 2010</a></li>\r\n\t\t\t\t\t</ul>\r\n\t\t\t\t</li>\r\n\t\t\t\t<li>Ensure that you acknowledge each FSN that applies to your organisation by returning the receipt to the manufacturer.</li></ul>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Distribution</h2><div class=\"content_section\" id=\"Distribution\">\r\n\t\t\t\t\t\t\t\t<p>This MDA has been distributed to:</p><ul>\r\n\t\t\t\t<li>NHS trusts in England (Chief Executives)</li>\r\n\t\t\t\t<li>HSC trusts in Northern Ireland (Chief Executives)</li>\r\n\t\t\t\t<li>NHS boards in Scotland (Chief Executives)</li>\r\n\t\t\t\t<li>NHS boards and trusts in Wales (Chief Executives)</li>\r\n\t\t\t\t<li>Primary care trusts in England (Chief Executives)</li></ul><p><font class=\"h3\">Onward distribution</font></p><p>Please bring this notice to the attention of all who need to know or be aware of it. This may include distribution by:</p><p><font class=\"h4\">Trusts to:</font><br>CAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:</p><ul>\r\n\t\t\t\t<li>A&amp;E consultants</li>\r\n\t\t\t\t<li>A&amp;E departments</li>\r\n\t\t\t\t<li>A&amp;E directors</li>\r\n\t\t\t\t<li>A&amp;E nurses</li>\r\n\t\t\t\t<li>Adult intensive care units</li>\r\n\t\t\t\t<li>All departments</li>\r\n\t\t\t\t<li>All staff</li>\r\n\t\t\t\t<li>All wards</li>\r\n\t\t\t\t<li>Anaesthetists</li>\r\n\t\t\t\t<li>Clinical governance leads</li>\r\n\t\t\t\t<li>Day surgery units</li>\r\n\t\t\t\t<li>Equipment stores</li>\r\n\t\t\t\t<li>General surgeons</li>\r\n\t\t\t\t<li>General surgery</li>\r\n\t\t\t\t<li>General surgical units, directors of</li>\r\n\t\t\t\t<li>Health and safety managers</li>\r\n\t\t\t\t<li>In-house maintenance staff</li>\r\n\t\t\t\t<li>Medical directors</li>\r\n\t\t\t\t<li>Medical oncologists</li>\r\n\t\t\t\t<li>MRI units, directors of</li>\r\n\t\t\t\t<li>Nursing executive directors</li>\r\n\t\t\t\t<li>Neurological surgeons</li>\r\n\t\t\t\t<li>Neurology and neurosurgery departments</li>\r\n\t\t\t\t<li>Occupational therapists</li>\r\n\t\t\t\t<li>Oncology nurse specialists</li>\r\n\t\t\t\t<li>Outpatient clinics</li>\r\n\t\t\t\t<li>Outpatient theatre managers</li>\r\n\t\t\t\t<li>Outpatient theatre nurses</li>\r\n\t\t\t\t<li>Palliative care teams</li>\r\n\t\t\t\t<li>Purchasing managers</li>\r\n\t\t\t\t<li>Radiation and medical oncology departments</li>\r\n\t\t\t\t<li>Radiation oncology, directors of</li>\r\n\t\t\t\t<li>Radiographers</li>\r\n\t\t\t\t<li>Radiologists</li>\r\n\t\t\t\t<li>Radiology departments</li>\r\n\t\t\t\t<li>Radiology directors</li>\r\n\t\t\t\t<li>Risk managers</li>\r\n\t\t\t\t<li>Supplies managers</li>\r\n\t\t\t\t<li>Theatre managers</li>\r\n\t\t\t\t<li>Theatre nurses</li>\r\n\t\t\t\t<li>Theatres</li></ul><p><font class=\"h4\">Care Quality Commission (CQC) (England only) to:</font><br>The MHRA considers this information to be important to:</p><ul>\r\n\t\t\t\t<li>Hospices</li>\r\n\t\t\t\t<li>Hospitals in the independent sector</li>\r\n\t\t\t\t<li>Independent treatment centres</li>\r\n\t\t\t\t<li>Private medical practitioners</li></ul><p><font class=\"h4\">Primary care trusts to:</font><br>CAS liaison officers for onward distribution to all relevant staff including:</p><ul>\r\n\t\t\t\t<li>Directors of public health</li>\r\n\t\t\t\t<li>Palliative care team</li>\r\n\t\t\t\t<li>Practice managers</li>\r\n\t\t\t\t<li>Practice nurses</li></ul>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Manufacturer Contact</h2><div class=\"content_section\" id=\"Manufacturer Contact\">\r\n\t\t\t\t\t\t\t\t<p>John Forsey<br>Cyberonics Europe<br>Unit 4 Dunston Innovation Centre<br>Dunston Road<br>Chesterfield&#160;<br>S41 8NG</p><p>Tel: 01246 261 397<br>Fax: 0870 166 0501&#160;</p><p>Email: <a href=\"mailto:europeclintechservices@cyberonics.com\">europeclintechservices@cyberonics.com</a>&#160;</p>\r\n\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Feedback</h2><div class=\"content_section\" id=\"Feedback\">\r\n\t\t\t\t\t\t\t\t<p>If you have any comments or feedback on this Medical Device Alert, please email us at: <a href=\"mailto:dts@mhra.gsi.gov.uk\">dts@mhra.gsi.gov.uk</a>&#160;</p>\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t<h2 class=\"sw\">England</h2><div class=\"content_section\" id=\"England\">\r\n\t\t\t\t\t\t\t\t\t<p>If you are in England, please send enquiries about this notice to the MHRA, quoting reference number <span>MDA/2010/050.</span></p><p><span>Technical aspects<br></span>Simon Holmes or Feza Haque<br>Medicines &amp; Healthcare products Regulatory Agency&#160;<br>Market Towers&#160;<br>1 Nine Elms Lane<br>London<br>SW8 5NQ</p><p>Tel: 020 7084 3240 / 3066<br>Fax: 020 7084 3106</p><p>Email: <a href=\"mailto:simon.holmes@mhra.gsi.gov\">simon.holmes@mhra.gsi.gov</a>&#160;or <a href=\"mailto:feza.haque@mhra.gsi.gov.uk\">feza.haque@mhra.gsi.gov.uk</a>&#160;</p><p><span>Clinical aspects</span><br>Dr Susanne Ludgate<br>Medicines &amp; Healthcare products Regulatory Agency<br>Market Towers<br>1 Nine Elms Lane<br>London SW8 5NQ<br><br>Tel: 020 7084 3123<br>Fax: 020 7084 3111&#160;</p><p>Email: <a href=\"mailto:susanne.ludgate@mhra.gsi.gov.uk\">susanne.ludgate@mhra.gsi.gov.uk</a></p><p><font class=\"h3\">How to report adverse incidents</font><br>Please report via our website: <a href=\"http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Devices/index.htm\">Reporting adverse incidents involving medical devices</a>.<br><br>Further information about CAS can be found on the <a href=\"https://www.cas.dh.gov.uk/Home.aspx\" target=\"_blank\">Central Alerting System website</a> (external link).</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Northern Ireland</h2><div class=\"content_section\" id=\"Northern Ireland\">\r\n\t\t\t\t\t\t\t\t\t<p>Alerts in Northern Ireland will continue to be distributed via the NI SABS system.</p><p>Enquiries and adverse incident reports in Northern Ireland should be addressed to:</p><p>Northern Ireland Adverse Incident Centre<br>Health Estates Investment Group<br>Room 17<br>Annex 6<br>Castle Buildings<br>Stormont Estate<br>Dundonald<br>BT4 3SQ</p><p>Tel: 02890 523 704<br>Fax: 02890 523 900</p><p>Email: <a href=\"mailto:NIAIC@dhsspsni.gov.uk\">NIAIC@dhsspsni.gov.uk</a></p><p><a href=\"http://www.dhsspsni.gov.uk/index/hea/niaic.htm\" target=\"_blank\">Northern Ireland Adverse Incident Centre (NIAIC)</a> (external link)</p><p><font class=\"h3\">How to report adverse incidents in Northern Ireland<br></font>Please report directly to NIAIC, further information can be found on the <a href=\"http://www.dhsspsni.gov.uk/niaic\" target=\"_blank\">NIAIC website</a> (external link).<br>Further information about SABS can be found on the <a href=\"http://sabs.dhsspsni.gov.uk/\" target=\"_blank\">SABS website</a> (external link).</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Scotland</h2><div class=\"content_section\" id=\"Scotland\">\r\n\t\t\t\t\t\t\t\t\t<p>Enquiries and adverse incident reports in Scotland should be addressed to:</p><p>Incident Reporting and Investigation Centre<br>Health Facilities Scotland<br>NHS National Services Scotland<br>Gyle Square<br>1 South Gyle Crescent<br>Edinburgh<br>EH12 9EB</p><p>Tel: 0131 275 7575<br>Fax: 0131 314 0722</p><p>Email: <a href=\"mailto:nss.iric@nhs.net\">nss.iric@nhs.net</a></p><p><a href=\"http://www.hfs.scot.nhs.uk/online-services/incident-reporting-and-investigation-centre-iric/\" target=\"_blank\">Health Facilities Scotland - Incident Reporting and Investigation Centre</a> (external link).</p>\r\n\t\t\t\t\t\t\t\t</div>\r\n<h2 class=\"sw\">Wales</h2><div class=\"content_section\" id=\"Wales\">\r\n\t\t\t\t\t\t\t\t\tEnquiries in Wales should be addressed to: <p>Dr Sara Hayes<br>Senior Medical Officer<br>Medical Device Alerts<br>Welsh Assembly Government<br>Cathays Park<br>Cardiff<br>CF10 3NQ</p><p>Tel: 029 2082 3922</p><p>Email: <a href=\"mailto:Haz-Aic@wales.gsi.gov.uk\">Haz-Aic@wales.gsi.gov.uk</a></p>\r\n\t\t\t\t\t\t\t\t</div>\r\n</div>\r\n\t\t\t", 
  "title": "Medical Device Alert: Implantable vagus nerve stimulators (VNS) manufactured by Cyberonics VNS Therapy (MDA/2010/050)", 
  "alert_type": [
    "devices"
  ], 
  "medical_specialism": []
}